MacAllister Trenton J, Stednick Zach, Golob Jonathan L, Huang Meei-Li, Pergam Steven A
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Infection Prevention, Seattle Cancer Care Alliance, Seattle, WA.
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Am J Infect Control. 2018 Jan;46(1):100-102. doi: 10.1016/j.ajic.2017.06.010. Epub 2017 Jul 27.
The development of a new laboratory-developed norovirus assay provided an opportunity to assess testing patterns, incidence, and outcomes of norovirus among hematopoietic cell transplant (HCT) recipients. Clostridium difficile and norovirus tests from 1,393 HCT recipients were compared in these analyses. In this population of high-risk patients, norovirus appeared to occur seasonally, but testing was infrequent despite a correlation with more severe disease when compared with patients with C difficile infection.
一种新的实验室开发的诺如病毒检测方法的出现，为评估造血细胞移植（HCT）受者中诺如病毒的检测模式、发病率及结果提供了契机。在这些分析中，对1393名HCT受者的艰难梭菌和诺如病毒检测结果进行了比较。在这群高危患者中，诺如病毒似乎呈季节性出现，但尽管与艰难梭菌感染患者相比，诺如病毒感染与更严重的疾病相关，但检测却并不常见。
